• Xamina travel sickness children 25 mg 6 soft capsules
1 1

Dompé

Xamamine travel sickness children 25 mg 6 soft capsules

Xamamine travel sickness children 25 mg 6 soft capsules

€8,84
€9,50 €8,84
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

6ct

EAN

002955108

MINSAN

002955108

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Seasickness, plane sickness, car sickness and train sickness.

CONTRAINDICATIONS

Hypersensitivity to the active substance, to other antihistamines or to any of the excipients. Contraindicated in children under 2 years of age. Contraindicated during pregnancy and breastfeeding.

WARNINGS AND PRECAUTIONS FOR USE

The product must be administered with caution in subjects suffering from closed-angle glaucoma, prostatic hypertrophy, urinary retention, slowed intestinal transit, bronchial asthma, epilepsy, porphyria. The product can mask the symptoms of ototoxicity and therefore must be administered with caution in patients receiving ototoxic drugs. The soft capsules contain sorbitol: Patients suffering from rare hereditary problems of fructose intolerance should not take this medicine. The soft capsules contain parabens which can cause allergic reactions (even delayed).

INTERACTIONS

The product may increase the effects of other Central Nervous System depressants, such as alcohol, barbiturates, other hypnotics, sedatives or tranquilizers. In case of concomitant intake of these substances, care must be taken to avoid additive sedation phenomena. The product may enhance the effects of other anticholinergic drugs, including antidepressants. If administered concomitantly with aminoglycoside antibiotics or other ototoxic drugs, dimenhydrinate can mask the first symptoms of ototoxicity, which can only be detected when the damage is irreversible (see also par. 4.4).

SIDE EFFECTS

Following treatment with Xamamine Travel Mal, the following side effects have been reported:

Systemic organ class | More frequent side effects | Frequent side effects | Less frequent side effects

Metabolism and nutrition disorders | Frequent side effects: Anorexia

Psychiatric disorders | Less frequent side effects: Insomnia (especially in children) Euphoria

Nervous system disorders | More frequent side effects: Sedation Drowsiness | Frequent side effects: Headache | Less frequent side effects: Vertigo Tremors Seizures (especially in children)

Vision disorders | Frequent side effects: Accommodation disorders

Heart disorders | Less frequent side effects: Tachycardia

Vascular disorders | Less frequent side effects: Hypotension

Gastrointestinal disorders | Frequent side effects: Dry mouth Nausea

Disorders of the skin and subcutaneous tissue | Frequent side effects: Photosensitivity Allergic skin reaction

Kidney and urinary disorders | Frequent side effects: Urination disorders

General disorders and administration site conditions | Less frequent side effects: Asthenia

"Reporting suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.